Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma PatientsBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseActive, not recruitingPhase 22026-03-05NCT04802356

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
GlaxoSmithKline294
PETHEMA Foundation21

12 results · Page 1 of 1

Swipe the table sideways for more columns.